Showing results (11-20 of 21) with videos related to
Sort By:
Pageof 3
Clinical Oncology (Royal College of Radiologists (Great Britain))|January 1, 1996
An audit of the management of malignant hypercalcaemiaG E Gerrard, D J Dodwell, A Vail, et al.Clinical Breast Cancer|March 20, 2002
Activity of pemetrexed (ALIMTA, multitargeted antifolate, LY231514) in metastatic breast cancer patients previously treated with an anthracycline and a taxane: an interim analysisM Spielmann, M Martin, M Namer, et al.British Journal of Cancer|April 1, 1993
High dose, dose-intensive chemotherapy with doxorubicin and cyclophosphamide for the treatment of advanced breast cancerJ E Ferguson, D J Dodwell, A M Seymour, et al.Clinical Oncology (Royal College of Radiologists (Great Britain))|January 1, 1994
Malignant schwannoma following treatment for Hodgkin's diseaseP M Fisher, D J Dodwell, L R Bridges, et al.Calcified Tissue International|December 1, 1991
The clearance and bioavailability of pamidronate in patients with breast cancer and bone metastasesP T Daley-Yates, D J Dodwell, M Pongchaidecha, et al.Postgraduate Medical Journal|June 1, 1992
Infusion rate and pharmacokinetics of intravenous pamidronate in the treatment of tumour-induced hypercalcaemiaD J Dodwell, A Howell, A R Morton, et al.Clinical Oncology (Royal College of Radiologists (Great Britain))|December 24, 2005
A randomised study of whole-breast vs tumour-bed irradiation after local excision and axillary dissection for early breast cancerD J Dodwell, K Dyker, J Brown, et al.Cancer Chemotherapy and Pharmacology|May 21, 2009
Dose-finding study of weekly docetaxel, epirubicin and capecitabine, as first-line treatment in advanced breast cancerS H Waters, A Gillibrand, H Berry, et al.BJS Open|March 25, 2020
Immediate and delayed autologous abdominal microvascular flap breast reconstruction in patients receiving adjuvant, neoadjuvant or no radiotherapy: a meta-analysis of clinical and quality-of-life outcomesA Khajuria, W N Charles, M Prokopenko, et al.Oncology|January 1, 1997
A randomised comparison of oestrogen suppression with anastrozole and formestane in postmenopausal patients with advanced breast cancerU R Kleeberg, M Dowsett, R P Carrion, et al.Pageof 3